A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC)
Autoimmune Disorder Inflammatory Bowel Disease (IBD) Ulcerative Colitis
For the latest version of this information please go to www.forpatients.roche.com